
Codoxray-CV 250mg/125mg Tablet DT
Marketer
Rayh Health Care
Salt Composition
Amoxycillin (250mg) + Clavulanic Acid (125mg)
Overview Codoxray-CV 250mg/125mg Tablet DT
Augmentin-equivalent 250mg/125mg tablets are a bacterial infection fighter. Effective against lung (pneumonia), ear, sinus, urinary tract, skin, and soft tissue infections, it's ineffective against viral illnesses like colds. For optimal stomach tolerance, take with food, following your doctor's prescribed schedule for consistent dosing. Complete the full course, even if symptoms improve, to prevent infection recurrence. Premature discontinuation risks bacterial survival and potential infection relapse. Common, typically mild, side effects include nausea, diarrhea, vomiting, oral/vaginal/skin fungal infections, rashes, and vaginitis. Report persistent or bothersome side effects to your physician. Prior to use, disclose antibiotic allergies, kidney or liver conditions, and all other medications to your doctor, as interactions are possible. Generally considered safe during pregnancy and breastfeeding under medical supervision.
Uses of Codoxray-CV 250mg/125mg Tablet DT
Managing bacterial illnesses
Major Benefits of Codoxray-CV 250mg/125mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Codoxray-CV 250mg/125mg DT tablet in water before consumption. Administer this medicine with food.
Common Side effects of Codoxray-CV 250mg/125mg Tablet DT:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Codoxray-CV 250mg/125mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Codoxray-CV 250mg/125mg Tablet DT in water before consumption. Administer this medicine with a meal.
How Codoxray-CV 250mg/125mg Tablet DT works:
Codoxray-CV 250mg/125mg extended-release tablets contain amoxicillin and clavulanate potassium. Amoxicillin, a penicillin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Clavulanate potassium, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Codoxray-CV 250mg/125mg DT tablets poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Codoxray-CV 250mg/125mg Delayed-Release Tablets during pregnancy is typically regarded as safe. Preclinical trials in animals have indicated minimal or no harmful effects on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Codoxray-CV 250mg/125mg Delayed-Release Tablets is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Codoxray-CV 250mg/125mg Tablet DT, due to potential side effects including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Codoxray-CV 250mg/125mg Tablet DT, as dosage modification may be necessary. Medical advice is recommended. Codoxray-CV 250mg/125mg Tablet DT is contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Codoxray-CV 250mg/125mg Tablet DT, as dose modification might be necessary. Medical advice is recommended. Routine liver function assessments are advised during treatment.
What if you forget to take Codoxray-CV 250mg/125mg Tablet DT :
Should you forget to take a Codoxray-CV 250mg/125mg Tablet DT, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Codoxray-CV 250mg/125mg Tablet DT
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
